BIOMAT Database Logo BIOMAT Database Logo

Aerosolised pentamidine for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome. 1990

A Weinberg, and S A Dantonio, and M I Duarte, and W L Pedreira Júnior, and A A Barone, and S Ishioka
Division of Infectious Diseases, Hospital das Clínicas of the University of São Paulo School of Medicine, Brazil.

The goal of this study was to evaluate inhaled pentamidine for the treatment of patients with mild and moderate Pneumocystis carinii pneumonitis. Eight adults with AIDS and pneumocystis pneumonia (4 with a first episode and 4 with a repeat pneumocystosis) received daily inhalations of aerosol pentamidine isethionate for 21 days. Six patients were treated with doses of 300 mg of pentamidine and the remaining 2 received 600 mg every day. In the 300 mg treatment group, 2 individuals showed discrete and transient neutropenia. However, both subjects that received 600 mg of aerosol pentamidine daily developed leukopenia. One of them had major toxicity (overall severe intolerance of 12.5%) that required drug discontinuation and did not allow any analysis of the treatment efficacy. Of the 7 evaluable patients, 6 (88%) completed the treatment successfully. One subject of the 300 mg regimen experienced an early recurrence. In conclusion, inhaled pentamidine is an effective treatment for mild and moderate cases of P. carinii pneumonia. It is less toxic than standard anti-pneumocystis therapy and is suitable for outpatient use.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009894 Opportunistic Infections An infection caused by an organism which becomes pathogenic under certain conditions, e.g., during immunosuppression. Infection, Opportunistic,Infections, Opportunistic,Opportunistic Infection
D010419 Pentamidine Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. Pentamidine Isethionate,Diamidine,Lomidine,NebuPent,Pentacarinat,Pentam,Pentamidin,Pentamidine Mesylate
D011020 Pneumonia, Pneumocystis A pulmonary disease in humans occurring in immunodeficient or malnourished patients or infants, characterized by DYSPNEA, tachypnea, and HYPOXEMIA. Pneumocystis pneumonia is a frequently seen opportunistic infection in AIDS. It is caused by the fungus PNEUMOCYSTIS JIROVECII. The disease is also found in other MAMMALS where it is caused by related species of Pneumocystis. P carinii Pneumonia,P. carinii Pneumonia,P. jirovecii Pneumonia,PCP Pneumonia,Pneumocystis Pneumonia,Pneumocystosis,Pneumonia, Interstitial Plasma Cell,PCP Infection,Pneumocystis carinii Pneumonia,Pneumocystis jirovecii Pneumonia,Pneumonia, Pneumocystis carinii,Infection, PCP,P carinii Pneumonias,P. carinii Pneumonias,P. jirovecii Pneumonias,PCP Infections,PCP Pneumonias,Pneumocystis Pneumonias,Pneumocystoses,Pneumonia, P carinii,Pneumonia, P. carinii,Pneumonia, P. jirovecii,Pneumonia, PCP,Pneumonia, Pneumocystis jirovecii,Pneumonias, PCP
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Weinberg, and S A Dantonio, and M I Duarte, and W L Pedreira Júnior, and A A Barone, and S Ishioka
Aerosolised pentamidine as sole therapy for Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.
August 1987, Lancet (London, England),
A Weinberg, and S A Dantonio, and M I Duarte, and W L Pedreira Júnior, and A A Barone, and S Ishioka
Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
July 1989, Thorax,
A Weinberg, and S A Dantonio, and M I Duarte, and W L Pedreira Júnior, and A A Barone, and S Ishioka
Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
October 1989, Thorax,
A Weinberg, and S A Dantonio, and M I Duarte, and W L Pedreira Júnior, and A A Barone, and S Ishioka
Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.
June 1993, Seminars in respiratory infections,
A Weinberg, and S A Dantonio, and M I Duarte, and W L Pedreira Júnior, and A A Barone, and S Ishioka
Miliary Pneumocystis carinii pneumonia in acquired immunodeficiency syndrome.
January 1992, International journal of STD & AIDS,
A Weinberg, and S A Dantonio, and M I Duarte, and W L Pedreira Júnior, and A A Barone, and S Ishioka
Pneumocystis Carinii pneumonia in pediatric acquired immunodeficiency syndrome.
June 1997, Indian pediatrics,
A Weinberg, and S A Dantonio, and M I Duarte, and W L Pedreira Júnior, and A A Barone, and S Ishioka
Two cases of Pneumocystis carinii pneumonia occurred in human immunodeficiency virus infected patients: supplemental treatment with aerosolised pentamidine isethionate.
January 1989, Japanese journal of medicine,
A Weinberg, and S A Dantonio, and M I Duarte, and W L Pedreira Júnior, and A A Barone, and S Ishioka
[Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome (AIDS)].
November 2002, Harefuah,
A Weinberg, and S A Dantonio, and M I Duarte, and W L Pedreira Júnior, and A A Barone, and S Ishioka
Severe neutropenia during pentamidine treatment of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome--New York City.
February 1984, MMWR. Morbidity and mortality weekly report,
A Weinberg, and S A Dantonio, and M I Duarte, and W L Pedreira Júnior, and A A Barone, and S Ishioka
Acquired immunodeficiency syndrome, Pneumocystis carinii pneumonia, and futility.
June 1996, Critical care medicine,
Copied contents to your clipboard!